Latest News

  • Alkermes to Host Conference Call to Discuss Second Quarter 2019 Financial Results Read More
  • Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder Read More
  • Alkermes Demonstrates Commitment to Local Community for 11th Consecutive Year With Largest Volunteer Event in Company History Read More

Investors

Working at Alkermes